NEWS & PERSPECTIVES
Psychedelics News
Curated updates on microdosing, research, policy, and community.
The latest
Psilocybin prevents chemotherapy-induced peripheral neuropathy through mitochondrial trafficking preservation
This preclinical mouse study found that psilocybin given before platinum- or taxane-based chemotherapy prevented peripheral neuropathy while preserving antitumour effects. The authors linked this protection to maintai...
Psilocybin prevents chemotherapy-induced peripheral neuropathy through mitochondrial trafficking preservation
This preclinical mouse study found that psilocybin given before platinum- or taxane-based chemotherapy prevented peripheral neuropathy while preserving antitumour effects. The authors linked this protection to maintai...
Safety, pharmacokinetics, and pharmacodynamics of intravenously administered deuterated-dimethyltryptamine (CYB004) in healthy volunteers
This randomised, double-blind, placebo-controlled study investigated intravenous CYB004, a deuterated DMT analogue, in healthy volunteers. At clinically relevant exposures, it produced psychedelic, brainwave and auton...
Inside the First Ayahuasca Forum Hosted by Indigenous Peoples
100 Indigenous leaders will gather at the World Ayahuasca Forum to set the terms for ayahuasca's future. [...] Read More... The post Inside the First Ayahuasca Forum Hosted by Indigenous Peoples appeared first on Doub...
Compass Pathways Recognized as a 2026 Fierce 50 Breakthrough Honoree
LONDON & NEW YORK, September 02, 2026--Compass Pathways, a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, has been named a 2026 Fierce 50…
Psychedelics may cause slight personality changes, but other factors play a big role
German college students who tried psychedelics for the first time showed slight increases in openness over a year. However, researchers say these minor personality shifts may simply reflect broader novelty-seeking beh...
Low-income group psilocybin assisted therapy for depression: An Oregon feasibility study
This open-label, uncontrolled feasibility study (n=19) found that group psilocybin therapy was practical for low-income adults with depression, with participants reporting improved depression and quality-of-life measu...
Serial Ketamine Infusions for Treatment-Resistant Bipolar Depression: A Randomized Clinical Trial
This double-blind randomised midazolam-controlled clinical trial (n=68) found that four intravenous ketamine infusions (35–53 mg/70 kg) over two weeks reduced depressive symptoms more than midazolam in adults with tre...
Low-income group psilocybin assisted therapy for depression: An Oregon feasibility study
This open-label, uncontrolled feasibility study (n=19) found that group psilocybin therapy was practical for low-income adults with depression, with participants reporting improved depression and quality-of-life measu...
Serial Ketamine Infusions for Treatment-Resistant Bipolar Depression: A Randomized Clinical Trial
This double-blind randomised midazolam-controlled clinical trial (n=68) found that four intravenous ketamine infusions (35–53 mg/70 kg) over two weeks reduced depressive symptoms more than midazolam in adults with tre...
A German study found slight personality changes after first-time psychedelic use were no longer statistically robust after accounting for other factors.
Among university students, first-time psychedelic users showed very small increases in Openness and small decreases in Conscientiousness over one year compared with nonusers. After adjusting for age, sex, income, ment...
Quantum BioPharma Announces Plans to Voluntarily Delist its Class B Shares from the Canadian Securities Exchange
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. TORONTO, Sept. 01, 2026…
Pα+ Psychedelic Bulletin #230: Pharma Ramps Up Ad Spend on Psychedelic Keywords; ARPA-H’s Ibogaine Funding; Psychedelics in Medicaid?
Pharma Ramps Up Google Ad Spend on Psychedelic Keywords Large pharmaceutical companies appear to be ramping up U.S. Google ad spend targeting psychedelics-related keywords, with the most common ads pointing to Johnson...
New study sheds light on how DMT alters brain waves to induce the loss of self
A new study reveals that the psychedelic drug DMT pushes brain waves into a highly random, structureless state. This biological shift directly correlates with the intense sensation of ego dissolution, shedding light o...
Can Psilocybin Protect Skin Cells From Premature Aging?
PLUS Carlos Castaneda, foraging for psilocybin mushrooms, and Resilient Pharmaceuticals. [...] Read More... The post Can Psilocybin Protect Skin Cells From Premature Aging? appeared first on DoubleBlind Mag.